In biochemical and cellular studies, Circle Pharma’s cyclin A/B RxL inhibitors have been shown ... Circle Pharma’s MXMO™ platform combines structure-based rational drug design and advanced ...

Circle Pharma, a clinical-stage biopharmaceutical company dedicated to discovering and developing a new generation of macrocycle therapies, today announced that preclinical data from its lead ...